Briefly noted:

A Tansel et al. Clin Gastroenterol Hepatol 2017; 15: 1207-17.  This systematic review and meta-analysis identified 25 studies and 6528 patients examining the relationship between autoimmune hepatitis (AIH) and hepatocellular carcinoma (HCC) .  In these studies the median followup was 8.0 years.  Key findings:

• The pooled incidence of HCC was 3.06 per 1000 patient-years
• 92 of 93 patients who had HCC had evidence of cirrhosis before or at the time of their diagnosis

My take: This study demonstrates that AIH patients with cirrhosis are at increased risk for HCC.  In patients with AIH who do not have cirrhosis, there does not appear to be a significant risk of HCC.

Also: Link for Online Resource for Hepatopulmonary Syndrome (Canadian Sponsored site). This site has content for patients and for practitioners, including a useful video.

Related blog posts:

• Increasing Incidence of Hepatocellular Carcinoma in the U.S.
• Hepatitis C Cure: Too Late for Many
• How strong is the case for HCC screening?
• Risk of HCC in NAFLD patients increasing
• Does NAFLD cause hepatocellular cancer?